These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4116302)

  • 81. Elevation of the erythrocyte sedimentation rate precedes exacerbation of bleomycin-induced pulmonary toxicity: report of two cases and review of literature.
    Higa GM; AlKhouri N; Auber ML
    Pharmacotherapy; 1997; 17(6):1315-21. PubMed ID: 9399618
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Phase II trials of methylglyoxal-bis (guanylhydrazone).
    Kelsen DP; Yagoda A; Warrell R; Chapman R; Whittes R; Gralla RJ; Casper E; Young CW
    Am J Clin Oncol; 1982 Apr; 5(2):221-5. PubMed ID: 7046414
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Indium-111 bleomycin complex for radiochemotherapy of head and neck cancer--dosimetric and biokinetic aspects.
    Kairemo KJ; Ramsay HA; Tagesson M; Jekunen AP; Paavonen TK; Jääskelä-Saari HA; Liewendahl K; Ljunggren K; Savolainen S; Strand SE
    Eur J Nucl Med; 1996 Jun; 23(6):631-8. PubMed ID: 8662096
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Randomized comparison of cis-diamminedichloroplatinum versus cis-diamminedichloroplatinum, methotrexate, and bleomycin in recurrent squamous cell carcinoma of the head and neck.
    Davis S; Kessler W
    Cancer Chemother Pharmacol; 1979; 3(1):57-9. PubMed ID: 93988
    [No Abstract]   [Full Text] [Related]  

  • 85. Induction chemotherapy with vinblastine, bleomycin, and cis-diamminedichloroplatinum in squamous cell carcinoma of the head and neck.
    Davis RK; Perry DJ; Zajtchuk JT
    Otolaryngol Head Neck Surg; 1983 Dec; 91(6):627-31. PubMed ID: 6198614
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A controlled evaluation of combined radiation and bleomycin therapy for squamous cell carcinoma of the esophagus.
    Earle JD; Gelber RD; Moertel CG; Hahn RG
    Int J Radiat Oncol Biol Phys; 1980 Jul; 6(7):821-6. PubMed ID: 6162830
    [No Abstract]   [Full Text] [Related]  

  • 87. [Antineoplastic antibiotics in the combined chemotherapy of squamous cell carcinoma].
    Kupchan DZ
    Antibiot Khimioter; 1988 May; 33(5):367-70. PubMed ID: 3415393
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Cisplatinum and bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: a randomised factorial phase III controlled trial.
    Morton RP; Rugman F; Dorman EB; Stoney PJ; Wilson JA; McCormick M; Veevers A; Stell PM
    Cancer Chemother Pharmacol; 1985; 15(3):283-9. PubMed ID: 2414023
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effects of bleomycin on human and experimental squamous carcinoma.
    Michaels L; Grey PA; Rowson KE
    J Pathol; 1972 Jan; 106(1):Pxi. PubMed ID: 4113823
    [No Abstract]   [Full Text] [Related]  

  • 90. [Combined treatment of malignant tumor with irradiation and bleomycin].
    Yamashita H; Nagase T; Kamata R; Nakajo H; Gomi M
    Nihon Gan Chiryo Gakkai Shi; 1972 Apr; 7(1):1-15. PubMed ID: 4122889
    [No Abstract]   [Full Text] [Related]  

  • 91. Treatment of locally advanced squamous cell carcinoma of the head and neck with concurrent bleomycin and external beam radiation therapy.
    Seagren SL; Byfield JE; Nahum AM; Bone RC
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1531-5. PubMed ID: 94057
    [No Abstract]   [Full Text] [Related]  

  • 92. Bleomycin therapy and ototoxicity.
    Dal I; Edsmyr F; Stahle J
    Acta Otolaryngol; 1973 Apr; 75(4):323-4. PubMed ID: 4122085
    [No Abstract]   [Full Text] [Related]  

  • 93. [Primary effect of NK 631 against head-and-neck cancers (author's transl)].
    Takata K; Honda T
    Jpn J Antibiot; 1979 Jan; 32(1):106-14. PubMed ID: 84880
    [No Abstract]   [Full Text] [Related]  

  • 94. Phase II trial of cis-diamminedichloroplatinum (cis-platinum), vincristine, and peplomycin for advanced squamous cell carcinoma.
    Tamura K; Araki Y; Tateyama H; Maeda M; Seita M
    J Surg Oncol; 1987 Aug; 35(4):241-4. PubMed ID: 2441207
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Combined preoperative treatment with cobalt and bleomycin in patients with head and neck carcinoma--a controlled clinical study.
    Kapstad B; Bang G; Rennaes S; Dahler A
    Int J Radiat Oncol Biol Phys; 1978; 4(1-2):85-9. PubMed ID: 75878
    [No Abstract]   [Full Text] [Related]  

  • 96. Chemotherapy of squamous head and neck cancer: a prospective randomized trial comparing cis-platinum and bleomycin with methotrexate and vindesine.
    von Heyden HW; Schröder M; Scherpe A; Borghardt J; Beyer JH; Nagel GA; Gerhartz H; Foth B; Kastenbauer E; Westerhausen M
    Recent Results Cancer Res; 1985; 98():148-52. PubMed ID: 2412266
    [No Abstract]   [Full Text] [Related]  

  • 97. [Clinical experience with bleomycin--a new cytostatic agent for cancer].
    Host H; Berdal P; Brennhovd IO; Ekroll T
    Tidsskr Nor Laegeforen; 1971 Apr; 91(10):714-6 passim. PubMed ID: 5089800
    [No Abstract]   [Full Text] [Related]  

  • 98. Effect of bleomycin on squamous cell carcinoma: preliminary observations.
    Van Rooyen CE; Haldane EV
    N S Med Bull; 1972 Oct; 51(5):144-50. PubMed ID: 4116503
    [No Abstract]   [Full Text] [Related]  

  • 99. Combined bleomycin and irradiation.
    Rygård J; Hansen HS
    Can J Otolaryngol; 1975; 4(2):209-12. PubMed ID: 49219
    [No Abstract]   [Full Text] [Related]  

  • 100. [New experiences with bleomycin].
    Wespi H
    ORL J Otorhinolaryngol Relat Spec; 1976; 38 Suppl 1():104-7. PubMed ID: 63931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.